GlobeNewswire Inc | Aug 3, 2020 08:07AM EDT

August 03, 2020

MARIETTA, Ga., Aug. 03, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (MiMedx or the Company), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission (SEC) in connection with its upcoming 2019 annual meeting of shareholders (Annual Meeting). The meeting is scheduled to be held on August 31, 2020 at 10:00 a.m. Eastern Time at www.virtualshareholdermeeting.com/MDXG2019. Shareholders as of the record date, 5:00 p.m. Eastern Time on July 14, 2020, are entitled to notice of, and to vote at, the Annual Meeting.

In light of public health concerns regarding the coronavirus (COVID-19) outbreak, the Annual Meeting will be conducted in a virtual format only to assist in protecting the health and well-being of our shareholders, directors and employees and to provide access to our shareholders regardless of geographic location.

The Company is mailing the definitive proxy statement (the Proxy Statement) and accompanying proxy card for the 2019 annual meeting of shareholders to its shareholders. A free copy of the Proxy Statement and other relevant documents that the Company files with the SEC may be obtained through the SECs website at www.sec.gov or at the Companys website at https://mimedx.com.

Contact:

Hilary DixonInvestor Relations & Corporate Communications770.651.9066investorrelations@mimedx.com